Total Payments
$3,889
2024 Payments
$730.78
Companies
24
Transactions
75
Medicare Patients
867
Medicare Billing
$273,836
Payment Breakdown by Category
Food & Beverage$3,875 (99.7%)
Travel$13.54 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,875 | 74 | 99.7% |
| Travel and Lodging | $13.54 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $776.08 | 10 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $578.01 | 6 | $0 (2018) |
| Lilly USA, LLC | $527.56 | 15 | $0 (2024) |
| Amgen Inc. | $374.71 | 4 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $273.15 | 9 | $0 (2019) |
| AbbVie, Inc. | $211.99 | 2 | $0 (2019) |
| Astellas Pharma US Inc | $167.26 | 3 | $0 (2023) |
| Sanofi Pasteur Inc. | $152.67 | 3 | $0 (2018) |
| GlaxoSmithKline, LLC. | $149.77 | 2 | $0 (2020) |
| Allergan Inc. | $127.22 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $730.78 | 23 | Lilly USA, LLC ($237.22) |
| 2023 | $526.64 | 10 | Novo Nordisk Inc ($270.57) |
| 2022 | $134.22 | 2 | Novo Nordisk Inc ($134.22) |
| 2021 | $121.87 | 1 | Novo Nordisk Inc ($121.87) |
| 2020 | $24.77 | 1 | GlaxoSmithKline, LLC. ($24.77) |
| 2019 | $623.89 | 9 | AbbVie, Inc. ($211.99) |
| 2018 | $844.24 | 15 | Sanofi Pasteur Inc. ($140.37) |
| 2017 | $882.12 | 14 | SANOFI-AVENTIS U.S. LLC ($471.25) |
All Payment Transactions
75 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: GALLSTONES | ||||||
| 10/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $34.20 | General |
| Category: Obesity | ||||||
| 10/23/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $26.64 | General |
| Category: GI | ||||||
| 09/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Obesity | ||||||
| 09/13/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $32.47 | General |
| 08/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $6.74 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $6.43 | General |
| Category: Obesity | ||||||
| 06/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $6.72 | General |
| Category: Diabetes | ||||||
| 05/09/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $121.82 | General |
| Category: Diabetes | ||||||
| 05/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Inflammation | ||||||
| 05/03/2024 | Endo USA, Inc. | AVEED (Biological) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: UROLOGY | ||||||
| 04/25/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: Obesity | ||||||
| 04/25/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $4.27 | General |
| Category: Obesity | ||||||
| 04/24/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: Diabetes | ||||||
| 04/11/2024 | VIVUS LLC | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/15/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/28/2024 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $45.61 | General |
| Category: Dermatology | ||||||
| 02/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $122.11 | General |
| Category: Diabetes | ||||||
| 02/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Travel and Lodging | Cash or cash equivalent | $13.54 | General |
| Category: Diabetes | ||||||
| 02/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Obesity | ||||||
| 01/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $5.99 | General |
| Category: Diabetes | ||||||
| 01/23/2024 | Avion Pharmaceuticals | NP Thyroid 60 (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Hyperthyroidism | ||||||
| 01/12/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $6.93 | General |
| Category: Obesity | ||||||
| 12/20/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Biological | ||||||
| 12/08/2023 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $27.37 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 246 | 1,965 | $242,194 | $77,110 |
| 2022 | 9 | 246 | 1,984 | $247,508 | $84,528 |
| 2021 | 10 | 235 | 2,018 | $236,558 | $79,545 |
| 2020 | 7 | 140 | 757 | $77,481 | $32,653 |
Total Patients
867
Total Services
6,724
Medicare Billing
$273,836
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 358 | $89,500 | $26,841 | 30.0% |
| 98926 | Osteopathic manipulative treatment, 3-4 body regions | Office | 2023 | 35 | 356 | $24,920 | $13,499 | 54.2% |
| 97124 | Therapy procedure using massage, each 15 minutes | Office | 2023 | 35 | 670 | $34,900 | $12,134 | 34.8% |
| 97530 | Therapy procedure using functional activities | Office | 2023 | 36 | 343 | $23,324 | $11,238 | 48.2% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 25 | 133 | $39,900 | $6,952 | 17.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 52 | $15,200 | $3,582 | 23.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $4,800 | $923.88 | 19.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $3,850 | $806.72 | 21.0% |
| 72050 | X-ray of upper spine, 4-5 views | Office | 2023 | 13 | 13 | $3,250 | $589.56 | 18.1% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 17 | 17 | $2,550 | $544.51 | 21.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 346 | $86,100 | $26,648 | 31.0% |
| 98926 | Osteopathic manipulative treatment, 3-4 body regions | Office | 2022 | 34 | 352 | $24,640 | $13,546 | 55.0% |
| 97124 | Therapy procedure using massage, each 15 minutes | Office | 2022 | 34 | 682 | $35,476 | $12,530 | 35.3% |
| 97530 | Therapy procedure using functional activities | Office | 2022 | 42 | 355 | $24,492 | $11,905 | 48.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 26 | 77 | $23,100 | $8,052 | 34.9% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2022 | 25 | 125 | $37,500 | $6,835 | 18.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 14 | 14 | $7,000 | $2,628 | 37.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $6,800 | $1,860 | 27.4% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2022 | 14 | 16 | $2,400 | $522.91 | 21.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 33 | 191 | $44,700 | $14,673 | 32.8% |
| 98926 | Osteopathic manipulative treatment to 3-4 body regions | Office | 2021 | 31 | 330 | $23,100 | $13,024 | 56.4% |
| 97124 | Therapeutic massage to 1 or more areas, each 15 minutes | Office | 2021 | 31 | 668 | $34,736 | $12,270 | 35.3% |
| 97530 | Therapeutic activities to improve function, with one-on-one contact between patient and provider, each 15 minutes | Office | 2021 | 34 | 344 | $23,392 | $12,034 | 51.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 27 | 197 | $39,400 | $9,878 | 25.1% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 14 | 114 | $33,580 | $9,179 | 27.3% |
About Dr. Rotana Tek, D.O
Dr. Rotana Tek, D.O is a Internal Medicine healthcare provider based in Pasadena, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2012. The National Provider Identifier (NPI) number assigned to this provider is 1952665036.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rotana Tek, D.O has received a total of $3,889 in payments from pharmaceutical and medical device companies, with $730.78 received in 2024. These payments were reported across 75 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,875).
As a Medicare-enrolled provider, Tek has provided services to 867 Medicare beneficiaries, totaling 6,724 services with total Medicare billing of $273,836. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Internal Medicine
- Location Pasadena, CA
- Active Since 07/03/2012
- Last Updated 11/12/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1952665036
Products in Payments
- TOUJEO (Drug) $371.21
- Wegovy (Drug) $324.84
- TRULICITY (Drug) $233.60
- Prolia (Biological) $233.35
- Ozempic (Drug) $216.74
- SOLIQUA (Drug) $206.80
- MOUNJARO (Drug) $190.78
- Veozah (Drug) $167.26
- PENTACEL (Drug) $152.67
- ANORO (Drug) $125.00
- VRAYLAR (Drug) $124.99
- GVOKE HYPOPEN (Drug) $121.82
- Repatha (Biological) $120.14
- ZOSTAVAX (Biological) $118.05
- Saxenda (Drug) $112.64
- Creon (Drug) $100.00
- GARDASIL (Biological) $78.41
- ZEPBOUND (Drug) $70.71
- Xeomin (Biological) $45.61
- NP Thyroid 60 (Drug) $30.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pasadena
Dr. Yuan Yuan, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $523,801
Internal Medicine $523,801
Christopher Dagher, M.d, M.D
Internal Medicine — Payments: $103,615
Internal Medicine $103,615
Peter Haddad, M.d, M.D
Internal Medicine — Payments: $87,600
Internal Medicine $87,600
Dr. Andrew Williams, M.d, M.D
Internal Medicine — Payments: $85,273
Internal Medicine $85,273
Joseph Dellinger, Md, MD
Internal Medicine — Payments: $77,175
Internal Medicine $77,175
Dr. Helen Moon, M.d, M.D
Internal Medicine — Payments: $61,882
Internal Medicine $61,882